Australia vs Turkmenistan: New or unknown treatment history cases: Pulmonary, bacteriologically
Australia
767
in 2023
Turkmenistan
746
in 2022
Australia rank
116th
Turkmenistan rank
118th
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- Australia
- Turkmenistan
How they compare
Australia currently reports 767 against 746 in Turkmenistan, a difference of 21.
The two have swapped places 2 times across 10 shared years of data; in 2013 it was Turkmenistan ahead.
Australia ranks 116th and Turkmenistan ranks 118th of 197 countries.
Across the 2 decades both report, Australia averaged higher in 1 and Turkmenistan in 1.
Head to head by decade
| Decade | Australia | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 719.71 | 835.14 | 115.43 | Turkmenistan |
| 2020s | 732 | 606.67 | 125.33 | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Australia or Turkmenistan?
- Australia, at 767 against 746 in Turkmenistan as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Australia and Turkmenistan?
- 21, with Australia ahead.
- How many years of comparable data are there for Australia and Turkmenistan?
- 10 years are reported by both, from 2013 to 2022.
- How do Australia and Turkmenistan rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Australia ranks 116th and Turkmenistan ranks 118th of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.